| Business Summary | | West
Pharmaceutical
Services,
Inc.
applies
value-added
technologies
to
the
process
of
bringing
new
drug
therapies
and
healthcare
products
to
global
markets.
West's
technologies
include
the
design
and
manufacture
of
packaging
components
for
pharmaceutical,
healthcare
and
consumer
products;
research
and
development
of
drug
delivery
systems;
contract
manufacturing
and
packaging
services;
clinical
services;
contract
laboratory
services;
and
other
services
that
support
the
manufacturing,
filling
and
packaging
of
pharmaceutical,
healthcare
and
consumer
products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | WST
is
a
supplier
of
products
and
services
for
packaging
and
delivery
of
pharmaceutical,
healthcare
and
consumer
products.
The
Co's.
revenues
are
generated
from
sales
to
large
pharmaceutical
and
medical
device
companies.
For
the
six
months
ended
6/30/01,
sales
rose
5%
to
$233.4
million.
Net
income
decreased
16%
to
$8.5
million.
Results
reflect
an
increase
in
contract
services,
offset
by
the
inclusion
of
$4.5
million
in
restructuring
charges. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| William Little, 58 Chairman
and CEO | $553K | -- | Donald Morel, Jr., 43 Pres,
COO | 241K | -- | Steven Ellers, 50 Exec.
VP | 249K | $17K | George Bennyhoff, 57 Sr.
VP- HR and Public Affairs | -- | -- | Linda Altemus, 49 VP
of Fin. and Admin. | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|